Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ieva Sliesoraityte is active.

Publication


Featured researches published by Ieva Sliesoraityte.


Archives of Ophthalmology | 2012

BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome

Alejandro Estrada-Cuzcano; Robert K. Koenekoop; Audrey Sénéchal; Elfride De Baere; Thomy de Ravel; Sandro Banfi; Susanne Kohl; Carmen Ayuso; Dror Sharon; Carel B. Hoyng; Christian P. Hamel; Bart P. Leroy; Carmela Ziviello; Irma Lopez; Alexandre Bazinet; Bernd Wissinger; Ieva Sliesoraityte; Almudena Avila-Fernandez; Karin W. Littink; Enzo Maria Vingolo; Sabrina Signorini; Eyal Banin; Liliana Mizrahi-Meissonnier; E. Zrenner; Ulrich Kellner; Rob W.J. Collin; Anneke I. den Hollander; Frans P.M. Cremers; B. Jeroen Klevering

OBJECTIVE To investigate the involvement of the Bardet-Biedl syndrome (BBS) gene BBS1 p.M390R variant in nonsyndromic autosomal recessive retinitis pigmentosa (RP). METHODS Homozygosity mapping of a patient with isolated RP was followed by BBS1 sequence analysis. We performed restriction fragment length polymorphism analysis of the p.M390R allele in 2007 patients with isolated RP or autosomal recessive RP and in 1824 ethnically matched controls. Patients with 2 BBS1 variants underwent extensive clinical and ophthalmologic assessment. RESULTS In an RP proband who did not fulfill the clinical criteria for BBS, we identified a large homozygous region encompassing the BBS1 gene, which carried the p.M390R variant. In addition, this variant was detected homozygously in 10 RP patients and 1 control, compound heterozygously in 3 patients, and heterozygously in 5 patients and 6 controls. The 14 patients with 2 BBS1 variants showed the entire clinical spectrum, from nonsyndromic RP to full-blown BBS. In 8 of 14 patients, visual acuity was significantly reduced. In patients with electroretinographic responses, a rod-cone pattern of photoreceptor degeneration was observed. CONCLUSIONS Variants in BBS1 are significantly associated with nonsyndromic autosomal recessive RP and relatively mild forms of BBS. As exemplified in this study by the identification of a homozygous p.M390R variant in a control individual and in unaffected parents of BBS patients in other studies, cis - or trans -acting modifiers may influence the disease phenotype. CLINICAL RELEVANCE It is important to monitor patients with an early diagnosis of mild BBS phenotypes for possible life-threatening conditions.


European Journal of Human Genetics | 2016

An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients

Crystel Bonnet; Zied Riahi; Sandra Chantot-Bastaraud; Luce Smagghe; Mélanie Letexier; Charles Marcaillou; Gaëlle Lefevre; Jean-Pierre Hardelin; Aziz El-Amraoui; Amrit Singh-Estivalet; Saddek Mohand-Said; Susanne Kohl; Anne Kurtenbach; Ieva Sliesoraityte; Ditta Zobor; Souad Gherbi; Francesco Testa; Francesca Simonelli; Sandro Banfi; Ana Fakin; Damjan Glavač; Martina Jarc-Vidmar; Andrej Zupan; Saba Battelino; Loreto Martorell Sampol; Maria Antonia Claveria; Jaume Catala Mora; Shzeena Dad; Lisbeth Birk Møller; Jesus Rodriguez Jorge

Usher syndrome (USH), the most prevalent cause of hereditary deafness–blindness, is an autosomal recessive and genetically heterogeneous disorder. Three clinical subtypes (USH1–3) are distinguishable based on the severity of the sensorineural hearing impairment, the presence or absence of vestibular dysfunction, and the age of onset of the retinitis pigmentosa. A total of 10 causal genes, 6 for USH1, 3 for USH2, and 1 for USH3, and an USH2 modifier gene, have been identified. A robust molecular diagnosis is required not only to improve genetic counseling, but also to advance gene therapy in USH patients. Here, we present an improved diagnostic strategy that is both cost- and time-effective. It relies on the sequential use of three different techniques to analyze selected genomic regions: targeted exome sequencing, comparative genome hybridization, and quantitative exon amplification. We screened a large cohort of 427 patients (139 USH1, 282 USH2, and six of undefined clinical subtype) from various European medical centers for mutations in all USH genes and the modifier gene. We identified a total of 421 different sequence variants predicted to be pathogenic, about half of which had not been previously reported. Remarkably, we detected large genomic rearrangements, most of which were novel and unique, in 9% of the patients. Thus, our strategy led to the identification of biallelic and monoallelic mutations in 92.7% and 5.8% of the USH patients, respectively. With an overall 98.5% mutation characterization rate, the diagnosis efficiency was substantially improved compared with previously reported methods.


Advances in Experimental Medicine and Biology | 2012

Correlation Between Spectral Domain OCT Retinal Nerve Fibre Layer Thickness and Multifocal Pattern Electroretinogram in Advanced Retinitis Pigmentosa

Ieva Sliesoraityte; Eric Troeger; Antje Bernd; Anne Kurtenbach; Eberhart Zrenner

Our aim is to assess the correlation between retinal nerve fibre layer thickness and ganglion cell function by electrophysiological means in advanced retinitis pigmentosa (RP) patients. A prospective observational case–control study enrolled 12 RP patients (age average 44 ± 14 years) with concentric visual field loss (≤10o) and 12 healthy age-matched control for testing. The peripapillary retinal nerve fibre layer (RNFL) thickness was assessed by spectral domain optical coherence tomography. The VERIS system was used to record multifocal pattern electroretinograms (mfPERG), a measure of inner retinal functional output. Amplitudes of P1N2 component were 42 ± 14, 53 ± 25 and 42 ± 17 nV within temporal superior, temporal, and temporal inferior region in RP, and 174 ± 52, 171 ± 46 and 144 ± 15 nV respectively in the control group (p 0.05). The diminution of photoreceptors sensory inputs in advanced RP patients corresponds with reduced amplitudes in mulitifocal pattern electroretinogram, although RNFL measurements indicate no detectable loss of RGC.


Journal of Neuroscience Methods | 2011

A new DTL-electrode holder for recording of electroretinograms in animals

Andreas Schatz; Gabriel Willmann; H. Enderle; Ieva Sliesoraityte; Andre Messias; Karl U. Bartz-Schmidt; Eberhart Zrenner; Florian Gekeler

PURPOSE Contact lens electrodes (CLEs) are frequently used to register electroretinograms (ERGs) in small animals such as mice or rats. CLEs are expensive to buy or difficult to be produced individually. In addition, CLEs have been noticed to elicit inconstant results and they carry potential to injure the cornea. Therefore, a new electrode holder was constructed based on the clinically used DTL-electrode and compared to CLEs. MATERIAL AND METHODS ERGs were recorded with both electrode types in nine healthy Brown-Norway rats under scotopic conditions. For low intensity responses a Naka-Rushton function was fitted and the parameters V(max), k and n were analyzed. The a-wave, b-wave and oscillatory potentials were analyzed for brighter flash intensities (1-60 scot cds/m²). Repeatability was assessed for both electrode types in consecutive measurements. RESULTS The new electrode holder was faster in setting up than the CLE and showed lower standard deviations. No corneal alterations were observed. Slightly higher amplitudes were recorded in most of the measurements with the new electrode holder (except amplitudes induced by 60 cds/m²). A Bland-Altman test showed good agreement between the DTL holder and the CLE (mean difference 35.2 μV (Holder-CLE)). Pearsons correlation coefficient for test-retest-reliability was r=0.783. CONCLUSIONS The DTL holder was superior in handling and caused far less corneal problems than the CLE and produced comparable or better electrophysiological results. The minimal production costs and the possibility of adapting the DTL holder to bigger eyes, such as for dogs or rabbits, offers with broader application prospects.


international conference of the ieee engineering in medicine and biology society | 2010

Multimodal multidimensional imaging for visual system status assessment

Ieva Sliesoraityte; Eric Troeger; Anne Kurtenbach; Robert Wilke; Eberhart Zrenner

Non-invasive optical methods that enable in vivo or in situ visualization of tissue components are of particular relevance in ophthalmology, as they can provide key information about the relationship between the structure and function of the visual system. In this paper we present a semiautomated multimodal imaging tool for co-registration of images of retinal structure and its function, based on point correspondence. Decision support analysis was applied to define significant features for the multimodal mapping system, using a set of 1500 subjects who were affected by blindness associated hereditary retinal dystrophies. Additionally, the developed software was tested by two experienced observers using data from 25 subjects. Inter-observer and intra-observer reliability was determined. We conclude that semi-automated multimodal mapping could be a promising new tool for an individualized visual system status assessment that can be applied for the early diagnosis of blindness associated diseases. Moreover, this mapping approach should prove particularly appropriate for studying pathophysiology in inherited blindness associated diseases.


Investigative Ophthalmology & Visual Science | 2018

Phenotype Variations Caused by Mutations in the RP1L1 Gene in a Large Mainly German Cohort

Ditta Zobor; Gergely Zobor; Stephanie Hipp; Britta Baumann; Nicole Weisschuh; Saskia Biskup; Ieva Sliesoraityte; Eberhart Zrenner; Susanne Kohl

Purpose Mutations in the retinitis pigmentosa-1-like-1 (RP1L1) gene are the major cause of autosomal dominant occult macular dystrophy (OCMD), while recessive mutations have been linked to autosomal recessive retinitis pigmentosa (arRP). We present the clinical phenotype of a large German OCMD cohort, as well as four RP patients. Methods A total of 42 OCMD patients (27 families) and 4 arRP patients (3 families) with genetically confirmed mutations in RP1L1 were included. Genomic DNA was analyzed by targeted analysis of the c.133C>T;p.R45W mutation for all RP or macular dystrophy-related genes. All patients underwent ophthalmologic examination including psychophysical tests, electrophysiology, fundus autofluorescence (FAF), and spectral domain optical coherence tomography (SD-OCT). Follow-up time was up to 12 years. Results In 25 OCMD index patients genomic testing revealed the heterozygous mutation c.133C>T;p.R45W in RP1L1; one patient was homozygous for the mutation. Two OCMD patients displayed the variants c.3599G>A;p.G1200D and c.2849G>A;p.R950H, respectively, in a heterozygous state. All OCMD patients showed characteristic clinical findings and typical microstructural photoreceptor changes. Two arRP patients displayed the novel homozygous mutations c.3022C>T;p.Q1008* and c.1107G>A;p.W369*, respectively, while two RP-siblings carried the two heterozygous mutations c.455G>A;p.R152Q and c.5959C>T;p.Q1987*, the first also being novel. All arRP cases were mild with disease onset ≈30 years and preserved ERG-responses. Conclusions OCMD phenotype showed consistent clinical findings including classical microstructural changes on SD-OCT. An important hallmark of RP1L1-related OCMD is the dominant family history with reduced penetrance. Furthermore, novel mutations in association with arRP were identified, outlining the complexity of the protein.


Current Eye Research | 2018

Usher Syndrome and Color Vision

Anne Kurtenbach; Gesa Hahn; Christoph Kernstock; Stephanie Hipp; Ditta Zobor; Katarina Stingl; Susanne Kohl; Crystel Bonnet; Saddek Mohand-Said; Ieva Sliesoraityte; José-Alain Sahel; Isabelle Audo; Ana Fakin; Marko Hawlina; Francesco Testa; Francesca Simonelli; Christine Petit; Eberhart Zrenner

ABSTRACT Purpose: The aim of this study is to report on the results of color vision testing in a European cohort of patients with Usher syndrome (USH). We describe the results in relation to Usher type (USH1 and USH2), age and visual acuity. Methods and methods: The color vision of 220 genetically confirmed adult USH patients, aged 18–70 years, was analyzed with one of three methods: the Farnsworth D-15 Dichotomous test (D-15) along with the Lanthony desaturated 15 Hue tests (D-15d), the Roth 28-Hue test, or the Ishihara 14-plate test. Visual acuity was measured with either the ETDRS or the SNELLEN charts. The Confusion index, the Selectivity index and the Confusion angle were calculated for the panel tests and used for analysis. The numbers of plates that could not be read were analyzed for the Ishihara test. Results: For the panel tests, the degree of color loss (Confusion index) is similar in both subtypes of USH, but the polarization of error scores (Selectivity index) is significantly lower in USH1 than USH2, showing more diffuse errors than those found in USH2. There is no significant correlation between logMAR visual acuity and the Confusion or the Selectivity indices. Additionally, we find a significant correlation between patient age and the degree and the polarity of the loss only in USH2. There was no difference between USH1 and USH2 in the results of the Ishihara test. Conclusions: The examination of color vision in patients with USH shows a significant difference in the pattern of color vision loss in USH1 and USH2 patients, but not in the severity of the loss. In USH2, we find a correlation between patient age and the degree and the polarity of the loss. These results may be due to differences in the pathogenesis of retinal dystrophy in USH1 and USH2.


Translational Vision Science & Technology | 2014

A Test of a Model of Glaucomatous Damage of the Macula With High-Density Perimetry: Implications for the Locations of Visual Field Test Points

Donald C. Hood; Matthew Nguyen; Alyssa C. Ehrlich; Ali S. Raza; Ieva Sliesoraityte; Carlos Gustavo De Moraes; Robert Ritch; Ulrich Schiefer


Investigative Ophthalmology & Visual Science | 2011

Improvement of Visual Orientation and Daily Skills Mediated by Subretinal Electronic Implant Alpha IMS in Previously Blind RP Patients

Eberhart Zrenner; A. Bruckmann; Udo Greppmaier; Gernot Hoertdoerfer; Christoph Kernstock; Ieva Sliesoraityte; Krunoslav Stingl; Barbara Wilhelm


Orphanet Journal of Rare Diseases | 2015

Novel grading system for quantification of cystic macular lesions in Usher syndrome

Ieva Sliesoraityte; Tunde Peto; Saddek Mohand-Said; José-Alain Sahel

Collaboration


Dive into the Ieva Sliesoraityte's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susanne Kohl

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar

Eric Troeger

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar

Ditta Zobor

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge